Skip to main content
Anthony Chiurco, MD, Neurosurgery, Lawrenceville, NJ

Anthony Alfred Chiurco MD


Assistant Clinical Professor of Neurological Surgery

Join to View Full Profile
  • 3131 Princeton PikeBuilding 4, Suite 201Lawrenceville, NJ 08648

  • Phone+1 609-895-8898

  • Fax+1 609-895-8330

Dr. Chiurco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Neurological Surgery, 1971 - 1975
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Surgery, 1970 - 1971
  • Presbyterian Medical Center of the University of Pennsylvania Health System
    Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 1967 - 1968
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1967

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1976 - 2025
  • Neurological Surgery
    American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons
  • Fellow (FAANS) American Association of Neurological Surgeons

Press Mentions

  • Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer Research
    Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer ResearchJanuary 26th, 2021
  • Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed Glioblastoma
    Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed GlioblastomaApril 20th, 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: